²é¿´: 3383  |  »Ø¸´: 13

yunew80

Òø³æ (³õÈëÎÄ̳)


[½»Á÷] ÇóÖúÈçºÎ²éµ½ÍùÄêÖбêµÄ»ù½ðÉêÇëÊéÕªÒª

±¾È˵ÚÒ»´ÎдÇàÄê»ù½ð£¬Éí±ßûÓÐÈË׫д£¬Ïë²Î¿¼Ò»Ï±ðÈ˵İ汾£¬ÔÚ¹ú»ùÍøÉÏÖ»Äܲ鵽ÏîÄ¿Ãû³ÆºÍ±àºÅ£¬ÄÄλ¸ßÈ˴ͽ̣ºµ½ÄÄ¿ÉÒԲ鵽ÒÑÖÐÏîÄ¿µÄÕªÒª£¿Ð»Ð»
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qingmingwu

½ð³æ (ÕýʽдÊÖ)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë

»ù½ðÍøÓ¦¸ÃÓÐ
2Â¥2011-02-20 12:49:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hbhehe

ľ³æ (ÖøÃûдÊÖ)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë
yunew80(½ð±Ò+1): ºÜºÃ 2011-02-22 09:26:20

07ÄêÒÔǰµÄ¿ÉÒÔ´Ó»ù½ðί¾ÉÍøÕ¾²éÕªÒª¡£
3Â¥2011-02-20 13:38:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yunew80

Òø³æ (³õÈëÎÄ̳)


ÒýÓûØÌû:
Originally posted by hbhehe at 2011-02-20 05:38:08:
07ÄêÒÔǰµÄ¿ÉÒÔ´Ó»ù½ðί¾ÉÍøÕ¾²éÕªÒª¡£

ÇëÎÊ´óÏÀÄܸø»ù½ðί¾ÉÍøÕ¾µÄÍøÖ·Âð
4Â¥2011-02-20 14:28:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hbhehe

ľ³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by yunew80 at 2011-02-20 06:28:10:
ÇëÎÊ´óÏÀÄܸø»ù½ðί¾ÉÍøÕ¾µÄÍøÖ·Âð

http://npd.nsfc.gov.cn/ResearchNet_NSFC/index.aspx

µã»÷-->ÉúÃü¿ÆÑ§²¿£¬
µã»÷-->×ÊÖúÏîÄ¿£¬
µã»÷-->±êÌ⣬
×îºóµã»÷-->ÏîĿժҪ¡£
5Â¥2011-02-20 20:30:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

koushuiji88

Ìú¸Ëľ³æ (ÎÄ̳¾«Ó¢)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë
ÒýÓûØÌû:
Originally posted by hbhehe at 2011-02-20 12:30:27:
http://npd.nsfc.gov.cn/ResearchNet_NSFC/index.aspx

µã»÷-->ÉúÃü¿ÆÑ§²¿£¬
µã»÷-->×ÊÖúÏîÄ¿£¬
µã»÷-->±êÌ⣬
×îºóµã»÷-->ÏîĿժҪ¡£

¸ù±¾²é²»µ½
6Â¥2011-02-20 20:42:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏàÒÀÏà°é

½ð³æ (ÖøÃûдÊÖ)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë

Õâ¸öºÃѽ
7Â¥2011-02-20 20:45:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
yunew80(½ð±Ò+1):лл²ÎÓë
ÒýÓûØÌû:
Originally posted by yunew80 at 2011-02-20 03:27:28:
±¾È˵ÚÒ»´ÎдÇàÄê»ù½ð£¬Éí±ßûÓÐÈË׫д£¬Ïë²Î¿¼Ò»Ï±ðÈ˵İ汾£¬ÔÚ¹ú»ùÍøÉÏÖ»Äܲ鵽ÏîÄ¿Ãû³ÆºÍ±àºÅ£¬ÄÄλ¸ßÈ˴ͽ̣ºµ½ÄÄ¿ÉÒԲ鵽ÒÑÖÐÏîÄ¿µÄÕªÒª£¿Ð»Ð»

»ù½ðίû¹ØÏµµÄ»°Ã»°ì·¨²éµÄ¡£
²»¹ýÄã¿ÉÒÔËÑË÷Ò»ÏÂСľ³æ£¬ÒÔǰÓÐºÜ¶à³æ×ÓÌù¹ýµÄ
8Â¥2011-02-20 20:47:46
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hbhehe

ľ³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by koushuiji88 at 2011-02-20 12:42:34:
¸ù±¾²é²»µ½

¸ÕÊÔÓùý£¬ÀýÈ磺
Ãû³Æ£º¹²±í´ïRSVÖкͿ¹Ô­µÄDNAºÍ·Ç¸´ÖÆÐÍÏÙ²¡¶¾ÖØ×éÌåµÄ¹¹½¨¼°Æä±£»¤×÷ÓÃ
-------------------------------------------------------
ÖÐÎÄÕªÒª£º         RSVÊǵ¼ÖÂÓ¤Ó×¶ùÑÏÖØÏºôÎüµÀ¸ÐȾµÄ×îÖØÒªµÄ²¡¶¾²¡Ô­£¬Í¬Ê±Ò²ÊÇÒýÆðÀÏÈË·¢²¡ºÍËÀÍöµÄÖØÒªÔ­Òò¡£²¡¶¾¸ÐȾ»úÌåºóµÄÃâÒß±£»¤»úÖÆÉÐδÃ÷È·£¬Ò²ÎÞÌØÒìÐÔ·ÀÖη½·¨¡£ÒÔÕæºË±í´ïÖÊÁ£ºÍ·Ç¸´ÖÆÐÍÏÙ²¡¶¾ÎªÔØÌå¹²±í´ïRSVÁ½ÖÖÖкͿ¹Ô­FºÍG£¬²¢Ñо¿ÆäÃâÒß±£»¤×÷ÓÃÊÇ̽Ë÷RSVÒßÃçµÄÓÐÒæ³¢ÊÔ¡£Ä¿Ç°£¬ÒѾ­Íê³ÉÑо¿¼Æ»®ÖеÄÒ»Ð©ÖØÒªÄÚÈÝ£¬ÈçÁ½ÖÖRSVÖкͿ¹Ô­±àÂë»ùÒòµÄ¿Ë¡£¬ÖØ×éÏÙ²¡¶¾¼ò±ã¸ßЧµÄ¸Ä½¨·½·¨£¬¿É½øÐй²±í´ïµÄÏÙ²¡¶¾ÔØÌåϵͳµÄ¹¹½¨£¬·Ö±ð±í´ïFºÍGµ°°×µÄ·Ç¸´ÖÆÐÍÏÙ²¡¶¾ÖØ×éÌåµÄ¹¹½¨ºÍ¼ø¶¨¹¤×÷µÈ¡£ÒÑÅàÑøË¶Ê¿Ñо¿Éú3Ãû£¬·¢±íÂÛÎÄ4ƪ£¬ÆäÖкËÐÄÆÚ¿¯3ƪ¡£ÕâЩ¹¤×÷Ϊ¼ÌÐøÍê³ÉÓàϵĿÎÌâÈÎÎñµì¶¨ÁË»ù´¡¡£
ÖÐÎÄÖ÷Ìâ´Ê£º         ºôÎüµÀºÏ°û²¡¶¾£»ÏÙ²¡¶¾ÖØ×éÌ壻ÃâÒß±£»¤×÷Óã»ÖкͿ¹Ô­£»¹²±í´ï
Ó¢ÎÄÕªÒª:         Human respiratory syncytial virus (RSV) is the most important viral etiologic agent of pediatric lower respiratory tract disease worldwide. RSV disease is also responsible for considerable morbidity and mortality in the elderly. The mechanisms that contribute to the disease protection are not fully understood. Currently no safe and efficacious RSV vaccine is available. It will be helpful for the RSV vaccine program to investigate their expression and protective immunity of DNA and replication-defective adenoviral recombinants encoding the attachment (G) and fusion (F) protein. Till now, we have finished the clone and eukaryotic expression of F and G gene of subgroup A Long strain RSV, established a more effective and easier method for constructing recombinant adenovirus based on AdEasy System, constructed replication deficient adenovirus vector system used as expressing F and G protein simultaneously and the adenoviral recombinants expressing the F and G protein, respectively. All these achievements provide a good basis for further study.
Ó¢ÎÄÖ÷Ìâ´Ê£º         respiratory syncytial virus;protective immunity;adenovirus recombinant;neutralization antigen;co-expression
9Â¥2011-02-20 20:47:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yingying1588

ľ³æÖ®Íõ (ÎÄѧ̩¶·)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë

¿ÉÒÔ²é°É¡£
10Â¥2011-02-20 21:58:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

adang2002

Í­³æ (СÓÐÃûÆø)


¡ï
yunew80(½ð±Ò+1):лл²ÎÓë

¿ÉÒÔ²éѯ
11Â¥2011-02-20 22:53:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

willhunt

ľ³æ (³õÈëÎÄ̳)


¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Õâ¸öÁ´½Ó¿ÉÒÔ²éµÄ£¬¾Í²»ÖªµÀÈ«²»È«¡£
12Â¥2013-01-25 12:12:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jinglyy

½ð³æ (ÕýʽдÊÖ)


¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÒýÓûØÌû:
1101099Â¥: Originally posted by hbhehe at 2011-02-20 20:30:27
http://npd.nsfc.gov.cn/ResearchNet_NSFC/index.aspx

µã»÷-->ÉúÃü¿ÆÑ§²¿£¬
µã»÷-->×ÊÖúÏîÄ¿£¬
µã»÷-->±êÌ⣬
×îºóµã»÷-->ÏîĿժҪ¡£...

µã»÷¡ª¡ª±êÌ⣬Õâ¸öÊÇÖ¸µãÏîÄ¿µÄÌâÄ¿Âð£¿ÏîĿժҪ»¹ÊÇ¿´²»µ½ÄØ£¿
13Â¥2013-01-25 13:56:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

×¼²©Ê¿

½ð³æ (ÕýʽдÊÖ)


¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Õâ¸öÊDz»ÊÇÄܹ»²éµ½ÒѾ­½áÌâµÄÏîÄ¿£¬ÒѾ­È·ÈϹý£¬ÊÇÉêÇëʱµÄÕªÒª¡£

[ Last edited by ×¼²©Ê¿ on 2013-2-17 at 16:13 ]
14Â¥2013-02-17 12:41:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yunew80 µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û